IARC joins the COVID-19 and Cancer Taskforce

The International Agency for Research on Cancer (IARC), together with other leading organizations, has joined the global COVID-19 and Cancer Taskforce to help coordinate efforts to synthesize and rapidly disseminate data on how the coronavirus disease (COVID-19) pandemic is affecting cancer outcomes worldwide.

Through the Taskforce, IARC together with the Union for International Cancer Control (UICC), the International Cancer Screening Network (ICSN), the Canadian Partnership Against Cancer (CPAC), and Cancer Council NSW (Australia) has posted a Call for Expressions of Interest to the global modelling community, for researchers interested in joining a modelling consortium. This effort seeks to connect modellers and modelling teams in different countries in new collaborations that can help quantify the impact of the pandemic on cancer outcomes, resulting from disruptions in the delivery of preventive, screening, and therapeutic interventions.

As part of the same initiative, IARC is sending out a survey to population-based cancer registries worldwide through the International Association of Cancer Registries (IACR), the professional society of registries for which IARC provides the Secretariat. The aim of the survey is to assess the short-term and longer-term impacts of the pandemic on registry operations and subsequent data dissemination in different settings.

View the Call for Expressions of Interest: COVID-19 and Cancer Taskforce Global Modelling Consortium

CONTINUE READING ON www.iarc.fr